Print Page

引 致 更 改 给 病 人 的 产 品 资 讯 的 药 物 不 良 反 应 警 示
 
Australia: GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours (English only)
 
 
 
附件:
  1. Australia: GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours (English only)  
Related Information:
The United States: FDA Requests Removal of Suicidal Behavior and Ideation Warnin... 上载于 2026-01-14
Canada: Summary Safety Review: Glucagon-like Peptide 1 Receptor Agonists (GLP-1 ... 上载于 2025-03-28
The United Kingdom: MHRA finds evidence does not support a link between Glucagon... 上载于 2024-09-05
European Union: GLP-1 receptor agonists: available evidence not supporting link ... 上载于 2024-04-13
The United States: Update on FDA’s ongoing evaluation of reports of suicidal tho... 上载于 2024-01-12
European Union: GLP-1 receptor agonists’ review: PRAC requests further clarifica... 上载于 2023-12-02
Singapore: HSA is assessing the potential risk of suicidal thoughts and self-har... 上载于 2023-09-22
European Union: EMA statement on ongoing review of GLP-1 receptor agonists (Engl... 上载于 2023-07-12
 
back